PARIS, April 8, 2026 – AZmed, a leading artificial intelligence (AI) company in medical imaging, and RADIN Health, a U.S. cloud-based, all-in-one RIS, PACS, Dictation AI, Study orchestration platform, have come together under a strategic distribution agreement.
Through this partnership, RADIN will make AZmed's Rayvolve® products available across its nationwide network of outpatient imaging centers, hospitals, and radiology practices. This includes AZtrauma for detection of fractures and AZchest for analysis and triage of thoracic abnormalities.
According to a study published in the Journal of the American College of Radiology and reported by Harvey L. Neiman Health Policy Institute, the shortage of board-certified radiologists entering the workforce is projected to persist through 2055. There are thousands unfilled positions in radiology and a clear need to improve workflow efficiency, diagnostic support, and reading throughput.
"Radiologists want an AI solution that can be used immediately upon receipt of a study rather than having to open a separate system to access that data. Our Rayvolve® AI Suite provides the solution to both reduce diagnostic risk and improve workflow in practices, as they are placed at the point of care," said Julien Vidal, Chief Executive Officer of AZmed.
RADIN delivers that promise. Its cloud native AI empowered platform, built for speed and productivity, now intelligently processes nearly two million studies annually. Images and study documents and other data using DICOM SR (Structured Reporting) and AI OCR (including handwritten technologist sheets, notes, prescriptions, and prior reports) are automatically analyzed, processed and the extracted data intuitively presented with all clinical information at the fingertips of the radiologist to apply to the reports, expediting report creation. Using AI-assisted dictation mode, with no need to dictate punctuation or formatting, radiologists can generate structured reports and impressions in seconds, increasing reporting speed by up to 70% compared with legacy dictation systems.
AZmed SR images and data are intelligently integrated in RADIN PACS to support AI-driven reporting tool insights. There is no need for manual entry or risk of human error. "Our north star at RADIN is to eliminate every single disruption in radiology workflow. Now, by integrating with AZmed's AI solutions, we can consistently and immediately identify and triage fractures and critical thoracic pathologies before the radiologist ever opens the study. Our AI is fully optimized to support and prepare the radiologist for the study at hand. The partnership aligns perfectly with our mission to integrate image analysis solutions into our All-In-One SaaS platform," said Dr. Alejandro Bugnone, MSK radiologist and Chief Executive Officer of RADIN Health.
Cohen et al., in their 2026 article published in Radiography, report the clinical validation research underpinning this integration. The study evaluated the Rayvolve® products with 258,373 X-rays from 100 medical centers across 26 countries and 5 continents. Each examination was annotated through dual-reader consensus over three years of data collection.
AZtrauma and AZchest are used daily in RADIN by Total Medical Imaging whose outpatient imaging teleradiology practice identifies, triages and optimizes their radiologists reading workflow experience. At the upcoming RBMA PaRADigm conference (Orlando, Florida, April 12-15), RADIN Health will showcase AZmed's Rayvolve® products in a live demonstration at Booth #515.
About RADIN Health
RADIN HEALTH is a pioneering radiology SaaS company that enhances the efficiency, productivity, and scalability of hospitals, imaging centers and radiology practices. Using artificial intelligence (AI), machine learning (ML), and natural language processing (NLP), Radin Health offers an all-in-one, cloud-based, RIS, PACS, Dictation AI, and Select study orchestrator solution. For more information, visit www.radinhealth.com.
About AZmed
Founded in 2018, AZmed is a European MedTech company developing AI solutions for medical imaging. Its Rayvolve® AI Suite includes FDA-cleared and CE-marked tools, while its Rayscan® line is CE-marked. Used by more than 2,500 healthcare facilities worldwide, AZmed’s solutions improve diagnostic consistency and operational efficiency in medical imaging. Additional resources on AI-supported fracture detection and chest imaging are available on AZmed’s website.
Regulatory information
US - Medical device Class II according to the 510K clearances. Rayvolve: is a computer-assisted detection and diagnosis (CAD) software device to assist radiologists and emergency physicians in detecting fractures during the review of radiographs of the musculoskeletal system. Rayvolve is indicated for adult and pediatric population (≥ 2 years).
Rayvolve PTX/PE: is a radiological computer-assisted triage and notification software that analyzes chest x-ray images of patients 18 years of age or older for the presence of pre-specified suspected critical findings (pleural effusion and/or pneumothorax). Rayvolve LN: is a computer-aided detection software device to assist radiologists to identify and mark regions in relation to suspected pulmonary nodules from 6 to 30mm size of patients of 18 years of age or older
EU - Rayvolve: Medical Device Class IIa in Europe (CE 2797) in compliance with the Medical Device Regulation (2017/745). Rayvolve is a computer-aided diagnosis tool, intended to help radiologists and emergency physicians to detect and localize abnormalities on standard X-rays.
Caution: The data mentioned are sourced from internal documents, internal studies and literature reviews. This material with associated pictures is non-contractual. It is for distribution to Health Care Professionals only and should not be relied upon by any other persons. Testimonial reflects the opinion of Health Care Professionals, not the opinion of AZmed. Carefully read the instructions for use before use. Please refer to our Privacy policy on our website For more information, please contact contact@azmed.co.
AZmed 10 rue d’Uzès, 75002 Paris - www.azmed.co - RCS Laval B 841 673 601
© 2026 AZmed – All rights reserved. MM-26-10
